Dermata Therapeutics share price logo

Dermata Therapeutics

NASDAQ: DRMA

$1.72

+0.09

(+5.52%)

as on

Dermata Therapeutics Stock Performance

as on August 26, 2026 at 2:16 pm IST

  • Day's Low

    $1.50
    $1.72
    downward going graph

    12.79%

    Downside

  • 52 Week's Low

    52 Week's High

    $0.95
    $6.22
    downward going graph

    44.72%

    Downside

    261.91%

    Upside

    downward going graph

Dermata Therapeutics share price movements today

Previous Close
$1.63
Open
$1.62
Volume
411.7K
Market Cap
$5.9M
Day's Low - High
$1.50 - $1.72
52 Week Low - High
$0.95 - $6.22

Dermata Therapeutics Historical Returns

1 Month Return
+ 9.77 %
3 Month Return
+ 22.69 %
1 Year Return
-75.59 %
3 Year Return
-99.2 %
5 Year Return
-99.99 %

Dermata Therapeutics Stock Fundamentals & Key Indicators

Check Dermata Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.9M

EPS (TTM)

-4.39

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.36

Industry PE ratio

-1.5966015625

PEG Ratio

-0.0012253581421069108

EBITDA

-8.5M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-166.67%

Dermata Therapeutics Stock Valuation

Track how Dermata Therapeutics P/E has moved over time to understand its valuation trends.

Dermata Therapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-2.75x)

December 31, 2021

Industry (-1.60x)

December 31, 2025

Today (-0.28x)

December 31, 2025

Highest (-0.02x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -0.28x

Dermata Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Dermata Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$5.9M-99.99%-0.360.00%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$25.3B-84.24%-7.98-12.57%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Dermata Therapeutics Stock including INR - Dollar returns

The Dermata Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Dermata Therapeutics investment value today

Current value as on today

₹31,324

Returns

-₹68,676

(-68.68%)

Returns from Dermata Therapeutics Stock

-₹71,237 (-71.24%)

Dollar Impact

₹2,561 (+2.56%)

Analyst Recommendation on Dermata Therapeutics Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Dermata Therapeutics. Average target price of $4

Dermata Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Dermata Therapeutics.

What analysts predicted

57%UPSIDE

Target Price

$4

Current Price

$1.72

Analyzed by

1 Analysts

Target

$4.00

Dermata Therapeutics target price $4, a slight upside of 57% compared to current price of $1.72. According to 1 analysts rating.

Indian Investors' Interest in Dermata Therapeutics Stock

Search interest for Dermata Therapeutics Stock has increased by 416% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:416% versus previous 30 day period

Dermata Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-3
-2
-3
-3
-2
-1
-1
-1
-1
-3
EBITDA
-3
-2
-3
-3
-2
-1
-1
-1
-1
-2
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-3
-2
-3
-3
-2
-1
-1
-1
-1
-2
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-3
-2
-3
-3
-2
-1
-1
-1
-1
-2
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Dermata Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
Gross Profit
0
0
-
-
-
-
-
Operating Income
-4
-3
-7
-9
-8
-12
-7
EBITDA
-4
-3
-7
-9
0
-12
-7
Interest Expense
0
0
0
0
-
-
-
Depreciation
0
0
-
-
8
-
-
Income Before Tax
-4
-3
-7
-9
-7
-12
-7
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-4
-3
-7
-9
-7
-12
-7
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Dermata Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-3
-2
-3
-3
-2
-1
-1
-1
-1
-2
Operating Cash Flow
-2
-2
-3
-2
-1
-2
-1
-1
-2
-2
Investing Cash Flow
-
-
-
-
-
-
-
-
-
0
Financing Cash Flow
-
2
4
0
8
0
0
4
1
0
Change in Cash
-2
0
1
-2
6
-3
-1
2
0
-2

Dermata Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-4
-3
-7
-9
-7
-12
-7,558
Operating Cash Flow
-3
-4
-5
-8
-6
-11
-7,757
Investing Cash Flow
-
-
-
-
-
-
-
Financing Cash Flow
4
2
15
4
7
6
12,117
Change in Cash
0
-1
10
-4
1
-4
4,360

Mutual Funds that own Dermata Therapeutics Stock

Check out the Mutual Funds with significant holdings in Dermata Therapeutics.

Funds
Holdings
Shares Held
Fidelity Concord Street Trust
0.563033%
22646

Global Institutional Holdings in Dermata Therapeutics

Funds
Holdings
Bank of America Corp
0%
Geode Capital Management, LLC
1.2%
Welch & Forbes LLC
0.5%
UBS Group AG
0.89%
Mcf Advisors, LLC
0.04%

Dermata Therapeutics News & Key Events

  • img

    Today's Timeline - 30 December

    Tue, 11:24 AM

    -

    Dermata Therapeutics closes $12.4 million private placement, shares rise 10.2% in after-hours trading.

Insights on Dermata Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, DRMA stock has moved up by 17.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 542.3% return, outperforming this stock by 611.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 41.9% return, outperforming this stock by 140.8%

About Dermata Therapeutics

Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
OrganisationDermata Therapeutics
Headquarters3525 Del Mar Heights Rd., San Diego, CA, United States, 92130
IndustryBiotechnology
CEOMr. Gerald T. Proehl
E-voting on sharesClick here to vote

Key Management of Dermata Therapeutics

Name

Title

Mr. Gerald T. Proehl

Founder, President, CEO & Chairman

Mr. David F. Hale

Co-Founder & Lead Independent Director

Ms. Kyri K. Van Hoose CPA, M.B.A.

Senior VP & CFO

Dr. Christopher J. Nardo M.P.H., Ph.D.

Senior VP & Chief Development Officer

Mr. Sean Proehl

Associate General Counsel

Ms. Kyra Peckaitis

Vice President of Marketing

Dr. Maria Bedoya Toro Munera M.B.A., Ph.D.

Senior Vice President of Regulatory Affairs & Quality Assurance

FAQs

What is Dermata Therapeutics share price today?

Dermata Therapeutics share price today is $1.72 as on at the close of the market. Dermata Therapeutics share today touched a day high of $1.72 and a low of $1.50.

What is the 52 week high and 52 week low for Dermata Therapeutics share?

Dermata Therapeutics share touched a 52 week high of $6.22 on and a 52 week low of $0.95 on . Dermata Therapeutics stock price today i.e. is closed at $1.72,which is 72.37% down from its 52 week high and 80.88% up from its 52 week low.

What is Dermata Therapeutics's market capitalisation today?

Dermata Therapeutics market capitalisation is $0.00T as on .

How to invest in Dermata Therapeutics Stock (DRMA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Dermata Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dermata Therapeutics Shares that will get you 0.8721 shares as per Dermata Therapeutics share price of $1.72 per share as on August 26, 2026 at 8:46 am IST.

What is the minimum amount required to buy Dermata Therapeutics Stock (DRMA) from India?

Indian investors can start investing in Dermata Therapeutics (DRMA) shares with as little as ₹95.41 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹954.10 in Dermata Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Dermata Therapeutics share’s latest price of $1.72 as on August 26, 2026 at 8:46 am IST, you will get 5.8140 shares of Dermata Therapeutics. Learn more about fractional shares .

What are the returns that Dermata Therapeutics has given to Indian investors in the last 5 years?

Dermata Therapeutics stock has given -99.99% share price returns and 29.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?